Myoshirt is a soft exoskeleton that supports the upper body while the user moves their arms.
The latest generation of the Ekso Bionics platform, the EksoNR previously received clearance for stroke and spinal cord rehabilitation in 2016, then acquired brain injury (ABI) in 2020
Sarcos demoed its Guardian XO, including the manipulation of a full sheet of plywood by using a vacuum gripper attached to the arm of the exoskeleton.
RobotCT’s UGO exoskeleton robot helps patients who experience motor dysfunction in the lower body learn how to walk.
For the full year 2021, Sarcos brought in $5.1 million in revenue, a decrease from the $8.8 million during 2020.
Researchers aim to improve the lives of people with neuro-motor impairments and to help individuals achieve ambitious fitness goals.
Atalante is a self-balanced, lower-body exoskeleton that emulates the way humans walk. The company began clinical trials for the exoskeleton in 2017. It was CE marked in 2019.
Ascend is intended to help those with knee pain perform everyday tasks, like walking, going up stairs or standing up.
The bioinspired system uses ultrasound measurements of muscle dynamics to develop a personalized and activity-specific assistance profile for users of the exosuit.
Sarcos said one-time expenses associated with the public merger with Rotor Acquisition Corp. led to increased losses.
Myomo said this is a 128% increase year over year and the highest quarterly revenue in the company’s history.
Terms of the deal were undisclosed, but Ottobock acquired 100% of suitX shares.
Sarcos announces that it will become publicly listed through a merger transaction with Rotor Acquisition Corp.
Robotics researchers are developing exoskeletons and prosthetic legs capable of making control decisions on their own using sophisticated artificial intelligence (AI) technology. The system combines computer vision and deep learning to mimic how able-bodied people walk by seeing their surroundings and adjusting their movements. “We’re giving robotic exoskeletons vision so they can control themselves,” said…
Exoskeleton users can now go from sitting to standing safely and without assistance based on the work of University of Michigan researchers, who developed an approach to create and test solutions to such problems virtually.
ReWalk Robotics, a developer of exoskeletons for people with lower-limb disabilities, is seeking to sell nearly 5.6 million ordinary shares, plus more, worth about $6.2 million. Marlborough, Mass.-based ReWalk is also offering more than 4.5 million ordinary shares which are issuable upon the exercise of outstanding warrants, according to a news release. ReWalk is also…
A new study highlights the importance of electrode placement when implanting sensory arrays for patients using a robotic hand.
The COVID-19 pandemic has brought attention to the need for innovative systems for stroke rehabilitation, said ReWalk Robotics, which donated a ReStore exo-suit to Brooks Rehabilitation.
Comau said its new MATE-XT exoskeleton is designed to be resistant to environmental conditions, is EWS-certified for reducing biomechanical risk, and can provide a demonstrable ROI.
The Toyota Unlimited Mobility Challenge will soon announce the winner of the $1 million first prize, and we caught up with the two U.S.-based teams among the five finalists working on EvoWalk and Quix wearable devices.
BIONIK Laboratories, which provides three InMotion therapeutic robots for neurological rehabilitation and the InMotion Connect data management system, is an example of how developers of assistive technology can work with hospitals.
In his RoboBusiness Direct session, recognized Harvard University professor Conor Walsh will examine how his team or researchers have developed soft, wearable robotics for industrial use.